Home Patent Forecast® Sectors Log In   Sign Up   Free Trial   Support   Contact   Pricing  
How it works Patent Forecast® Sectors Pricing Insights
Menu

Patent US0200327987
Inventor

!regextitle

Much More than Average Length Specification


1 Independent Claims

  • Claim 2. The method of claim 1, further comprising: receiving, from the client device, an indication to display a detailed representation of a particular genetic disorderand transmitting, to the client device, a web-based representation of a third graphical user interface, wherein the third graphical user interface is configurable to display a textual description of (i) the particular genetic disorder and (ii) how the particular genetic disorder is related to the endocannabinoid genotype of the user.
  • Claim 3. The method of claim 1, wherein the second graphical user interface is further configurable to display a personalized assessment to the user.
  • Claim 4. The method of claim 1, wherein receiving, by the server device, the DNA information associated with a user comprises receiving results of a DNA test kit supplied by the user.
  • Claim 5. The method of claim 1, wherein receiving, by the server device, the DNA information associated with a user comprises receiving the DNA information from a third-party laboratory.
  • Claim 6. The method of claim 1, wherein parsing, by the server device, the DNA information to identify one or more SNPs comprises removing the DNA information that is not associated with the endocannabinoid genotype of the user.
  • Claim 7. The method of claim 1, wherein receiving, by the server device, the DNA information associated with a user comprises receiving the DNA information from a third-party DNA information provider.
  • Claim 8. An article of manufacture including a non-transitory computer-readable medium, having stored thereon program instructions that, upon execution by a computing device, cause the computing device to perform operations comprising: receiving deoxyribonucleic acid (DNA) information associated with a userparsing the DNA information to identify one or more single nucleotide polymorphisms (SNPs)determining, based on the identified SNPs, an endocannabinoid genotype of the userdetermining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulationstransmitting, to a client device associated with the user, a web-based representation of a first graphical user interface, wherein the first graphical user interface is configurable to display information related to the user, wherein the information is related to the one or more cannabinoid formulations involving the endocannabinoid genotype of the userreceiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulationsand transmitting, to the client device, a web-based representation of a second graphical user interface, wherein the second graphical user interface is configurable to display (i) a textual description of the particular cannabinoid formulation, (ii) a textual description of an interaction between the particular cannabinoid formulation and the endocannabinoid genotype of the user, and (iii) a cannabidiol (CBD) to tetrahydrocannabinol (THC) ratio present in the particular cannabinoid formulation.
  • Claim 14. A computing device comprising: at least one processormemoryand program instructions, stored in the memory, that upon execution by the at least one processor cause the computing device to perform operations comprising: receiving deoxyribonucleic acid (DNA) information associated with a userparsing the DNA information to identify one or more single nucleotide polymorphisms (SNPs)determining, based on the identified SNPs, an endocannabinoid genotype of the userdetermining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulationstransmitting, to a client device associated with the user, a web-based representation of a first graphical user interface, wherein the first graphical user interface is configurable to display information related to the user, wherein the information is related to the one or more cannabinoid formulations involving the endocannabinoid genotype of the userreceiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulationsand transmitting, to the client device, a web-based representation of a second graphical user interface, wherein the second graphical user interface is configurable to display (i) a textual description of the particular cannabinoid formulation, (ii) a textual description of an interaction between the particular cannabinoid formulation and the endocannabinoid genotype of the user, and (iii) a cannabidiol (CBD) to tetrahydrocannabinol (THC) ratio present in the particular cannabinoid formulation.


View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >



Patent Matrix® Search


USPTO Patent Document Number